Fraqueza muscular no dia a dia pode ser sintoma de doença autoimune rara que acomete 40 mil brasileiros
07.08.2025 - 18:02:32 | prnewswire.co.uk
Acesso em 16 de maio de 2024.
2Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia Gravis: Epidemiology,Pathophysiology and Clinical Manifestations. J Clin Med. 2021;10(11):2235.
3National Institute of Neurological Disorders and Stroke. Myasthenia Gravis. Disponível em: https://www.ninds.nih.gov/health-information/disorders/myasthenia-gravis Acesso em 16 de maio de 2024.
4GROB D, ARSURA EL, BRUNNER NG, NAMBA T. The Course of Myasthenia Gravis and Therapies Affecting Outcome. Annals of the New York Academy of Sciences. 1987 Aug;505(1 Myasthenia Gr):472–99.
5Fang F, Sveinsson O, Thormar G, Granqvist M, Askling J, Lundberg IE, et al. The autoimmune spectrum of myasthenia gravis: a Swedish population-based study. Journal of Internal Medicine. 2014 Nov 13;277(5):594–604.
6Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S. Myasthenia gravis — autoantibody characteristics and their implications for therapy. Nature Reviews Neurology. 2016 Apr 22;12(5):259–68.
7Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. The Lancet Neurology [Internet]. 2009 May;8(5):475–90. Disponível em: http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2730933&blobtype=pdf
8Wendell LC, Levine JM. Myasthenic Crisis. The Neurohospitalist [Internet]. 2011 Jan;1(1):16–22. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726100/
2Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia Gravis: Epidemiology,Pathophysiology and Clinical Manifestations. J Clin Med. 2021;10(11):2235.
3National Institute of Neurological Disorders and Stroke. Myasthenia Gravis. Disponível em: https://www.ninds.nih.gov/health-information/disorders/myasthenia-gravis Acesso em 16 de maio de 2024.
4GROB D, ARSURA EL, BRUNNER NG, NAMBA T. The Course of Myasthenia Gravis and Therapies Affecting Outcome. Annals of the New York Academy of Sciences. 1987 Aug;505(1 Myasthenia Gr):472–99.
5Fang F, Sveinsson O, Thormar G, Granqvist M, Askling J, Lundberg IE, et al. The autoimmune spectrum of myasthenia gravis: a Swedish population-based study. Journal of Internal Medicine. 2014 Nov 13;277(5):594–604.
6Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S. Myasthenia gravis — autoantibody characteristics and their implications for therapy. Nature Reviews Neurology. 2016 Apr 22;12(5):259–68.
7Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. The Lancet Neurology [Internet]. 2009 May;8(5):475–90. Disponível em: http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC2730933&blobtype=pdf
8Wendell LC, Levine JM. Myasthenic Crisis. The Neurohospitalist [Internet]. 2011 Jan;1(1):16–22. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726100/
View original content:https://www.prnewswire.com/br/comunicados-para-a-imprensa/fraqueza-muscular-no-dia-a-dia-pode-ser-sintoma-de-doenca-autoimune-rara-que-acomete-40-mil-brasileiros-302158445.html
FONTE AstraZeneca
Hol dir jetzt den Wissensvorsprung der Aktien-Profis.
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen - Dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
Für. Immer. Kostenlos.
boerse | 68009477 |

